The product is disappearing into reorder rhythm: revenue is shifting from won-each-time to arriving-on-its-own, and the
The model's full reasoning — Q1 2018 call → NOWe need answer YES/NO. Need analyze transcript. Question: Does management describe that a growing share of revenue now arrives without new selling event (reorders, refills, renewals, repeat purchases, usage-driven billing, aftermarket/consumable pull-through, customers' own routines) AND that this self-arriving share has recently and visibly grown as proportion, with management grounding shift in observed current behavior and treating it as changing quality of revenue? We need use only transcript. Need determine if management explicitly conveys both halves. Transcript: Francis discusses revenue growth. Sequencing consumables revenue $417M grew 31%. "This performance was driven by consumables growth across our sequencing portfolio with notable strength in high throughput family, which grew 34%. As anticipated, consumables from our HiSeq family declined as customers transitioned to NovaSeq. So HiSeq consumables were down about $20 million sequentially, primarily among our ex-customers. Excluding the $19 million stocking order in the fourth quarter, NovaSeq consumables grew approximately 60% sequentially with strong performance from both S2 and S4 flow cells." This is consumable pull-through from installed instruments. They talk about "average pull-through rate at high end of $100,000 to $150,000 range" for NextSeq. "Library prep grew 20%... represents more than 10% of our sequencing consumable business." "We’re very pleased to see consumable growth across our entire instrument portfolio. It’s an important reminder that while NovaSeq is a key enabler for some of our customers. The growth in sequencing demand more broadly is a key driver of our business." This indicates consumables (recurring) growing. But does management describe that this self-arriving share has recently and visibly grown as proportion? They say "Reflecting strong demand for sequencing consumables, first quarter revenue of $417 million grew 31% from same quarter a year ago." They also mention "sequencing system revenue was $112 million... up 18%... down sequentially, as expected given normal capital equipment seasonality." So consumables are larger than instruments. But is there explicit statement that proportion has recently moved? They say "consumables growth across our entire instrument portfolio" and "NovaSeq consumables grew approximately 60% sequentially" etc.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
DUOT · Q4 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, through reorders, renewals, etc., and that this has recently and visibly grown as a ...
QTRX · Q3 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through reorders, consumables, etc., and that this share has recently grown.
CYBR · Q3 2021 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through renewals, and that this has recently grown as a proportion.